Given that these pathways are central to M1 macrophage activation (40–42), we propose that in BMDMs, CCL5 activates MAPK and NF-κB signaling via CCR1 and CCR5, leading to sustained M1 polarization and kidney damage. This evidence concerns the gene CCL5 and Nephropathy.